Longboard Pharmaceuticals, Inc. Common Stock
LBPH
LBPH was delisted on the 29th of November, 2024.
20 hedge funds and large institutions have $68.2M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
18% more funds holding
Funds holding: 17 → 20 (+3)
5% less capital invested
Capital invested by funds: $71.7M → $68.2M (-$3.51M)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$646K |
| 2 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$372K |
| 3 |
V
Veritable
Wilmington,
Delaware
|
+$189K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$148K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$140K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.22M |
| 2 |
Millennium Management
New York
|
-$497K |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$444K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$211K |
| 5 |
Renaissance Technologies
New York
|
-$95K |
LBPH Hedge Fund Activity: Q3 2021 in Review
20 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q3 2021, worth a combined $68.2M — down 4.9% from $71.7M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new LBPH positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $646K. The largest seller was Fidelity Investments, cutting an estimated $3.22M.
- 20 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q3 2021, up from 17 in Q2 2021.
- Funds reported $68.2M of Longboard Pharmaceuticals, Inc. Common Stock stock for Q3 2021, down 4.9% quarter-over-quarter.
- 6 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q3 2021 and 3 closed out, a net change of +3 holders.
- The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q3 2021 was Bridgeway Capital Management, an estimated $646K added.
- The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q3 2021 was Fidelity Investments, an estimated $3.22M sold.
Based on aggregated 13F filings for Q3 2021.